Literature DB >> 2468824

Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts.

T Kukita1, L M McManus, M Miller, C Civin, G D Roodman.   

Abstract

Long-term cultures of human bone marrow form multinucleated cells (MNC) with many functional characteristics of osteoclasts including: expression of tartrate-resistant acid phosphatase, appropriate responses to osteotropic hormones, calcitonin-induced contraction and formation of resorption lacunae on calcified matrices. However, it is unclear if these cells express similar surface antigens as expressed by authentic osteoclasts, since they form on plastic surfaces in the absence of bone. Bone may be required to complete the differentiation process for osteoclasts. Therefore, we have examined the surface phenotype of MNC and compared it with that of osteoclasts freshly isolated from bone, to determine if MNC express similar surface antigens, and if MNC express antigens which identify their cellular origin. Similar to bone-derived osteoclasts, MNC formed in long-term human bone marrow culture expressed osteoclast-specific antigens (detected by monoclonal antibodies 13c2 and 23c6) and did not express Fc receptors, T cell specific antigens, most myeloid antigens or mature macrophage antigens. In contrast to authentic osteoclasts, MNC reacted with a monoclonal antibody (Mol) which identifies an antigen present on myeloblasts, monocytes, granulocytes, and null cells from human peripheral blood and bone marrow. MNC also reacted with the monoclonal antibody My11, which is present on CFU-GM, the granulocyte-macrophage colony-forming cell, the probable precursor for MNC. These data demonstrate that MNC formed in long-term human marrow cultures express a similar surface phenotype to osteoclasts. This phenotype is different from that expressed by macrophage polykaryons. In addition, MNC also expressed monocyte-related antigens (My11, Mol), suggesting that are derived from or related to the monocytic lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468824

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.

Authors:  A Kukita; C Chenu; L M McManus; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.

Authors:  C Menaa; R D Devlin; S V Reddy; Y Gazitt; S J Choi; G D Roodman
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes.

Authors:  N A Athanasou; J I Alvarez; F P Ross; J M Quinn; S L Teitelbaum
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

6.  An assessment of the ability of human bone marrow cultures to generate osteoclasts.

Authors:  A M Flanagan; M A Horton; E L Dorey; D A Collins; R S Evely; J M Moseley; F C Firkin; T J Chambers; M H Helfrich; T J Martin
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

7.  Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Authors:  S Takahashi; S Goldring; M Katz; S Hilsenbeck; R Williams; G D Roodman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Osteoinductive factor inhibits formation of human osteoclast-like cells.

Authors:  A Kukita; L Bonewald; D Rosen; S Seyedin; G R Mundy; G D Roodman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.

Authors:  A M Flanagan; M D Stow; N Kendall; W Brace
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

10.  Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath.

Authors:  N A Athanasou; J Quinn; D J Ferguson; J O McGee
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.